Clinical Trials on Treatment for Submental Fat in United Kingdom

Total 11995 results

Kythera Biopharmaceuticals

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada, Australia, United Kingdom
Raziel Therapeutics Ltd.

Completed

Efficacy and Safety of RZL-012 on Submental Fat Reduction

Submental Fat

United States
10xBio, LLC

Completed

A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

An Open-label Study That Will Test a Second Treatment Session of RZL-012.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.

Submental Fat

United States
Raziel Therapeutics Ltd.

Completed

Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events

Submental Fat

United States
10xBio, LLC

Active, not recruiting

A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat

Submental Fat

United States
Neothetics, Inc

Completed

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada
Kythera Biopharmaceuticals

Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Australia, Canada, United Kingdom
Kythera Biopharmaceuticals

Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)

Moderate or Severe Submental Fullness

United Kingdom, Canada, Australia
Rejuven Dermaceutical Co., Ltd.

Completed

RJV001 Study in Adults Receiving Abdominoplasty

Submental Fat (SMF) | Double Chin

United States
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Belgium, France, Germany, Italy, Spain, United Kingdom
Kythera Biopharmaceuticals
Bayer

Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

Moderate or Severe Submental Fullness

Germany, France, Belgium, Spain, United Kingdom
Kythera Biopharmaceuticals

Completed

Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age

Efficacy | Safety | Moderate to Severe Convexity of Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Efficacy | Safety | Moderate to Severe Convexity of Submental Fat

United States
Kythera Biopharmaceuticals

Completed

Patient Experience Study of Deoxycholic Acid Injection

Moderate or Severe Submental Fullness

United States
Imperial College London

Completed

Predictive Model of Therapy Outcomes in Breast Cancer Patients

Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.

United Kingdom
Kythera Biopharmaceuticals

Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

Moderate or Severe Submental Fullness

United States
Kythera Biopharmaceuticals

Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Moderate or Severe Submental Fullness

United States
Kythera Biopharmaceuticals

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (REFINE-1)

Moderate or Severe Submental Fullness

United States, Canada
Kythera Biopharmaceuticals

Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Moderate or Severe Submental Fullness

United States, Canada
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification

Radiation Treatment for Tumors

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Treatment for Bipolar I Disorder

United States
Manchester University NHS Foundation Trust

Completed

Web-based Adherence Information Integrated Nurse-led Monitoring Clinic (WAIN-MC)

Growth Hormone Treatment | Short Stature

United Kingdom
Amgen

Completed

Registry Study for Talimogene Laherparepvec

Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial

Canada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
Barts & The London NHS Trust

Completed

Lymphocyte Immunophenotyping in Common Variable Immunodeficiency

Bronchiectasis | Common Variable Immunodeficiency | Granulomatous Disease | Immunoglobulin Treatment

United Kingdom
Texas Christian University

Active, not recruiting

Mapping Approaches to Prepare for Implementation Transfer (MAP-IT) (MAP-IT)

Mapping Approaches to Prepare for Implementation Transfer | Treatment Readiness and Induction Program

United States
University of Oxford
Wellcome Trust

Recruiting

Mechanisms of Neurodynamic Treatments (MONET)

Carpal Tunnel Syndrome | Physiotherapy | Neurodynamic Treatment | Nerve Mobilisation | Diffusion MRI | Mechanistic Trial

United Kingdom
University of Pittsburgh

Withdrawn

Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT)

Breast Cancer | Mastectomy, Segmental | Lumpectomy

United States
Cutera Inc.

Completed

Multi-Center Pilot Study of Cutera truSculpt Device

Treatment for Cellulite on the Stomach and Flanks

United States
UCB Pharma

Completed

Named Patient Program With Rotigotine Transdermal System

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

United States
Cytori Therapeutics

Completed

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy (RESTORE-2)

Breast Neoplasms | Carcinoma, Ductal, Breast | Mammaplasty | Mastectomy, Segmental, Lumpectomy, Breast Reconstruction,

Spain, United Kingdom, Belgium, Italy
VA Office of Research and Development
Yale University

Completed

Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims (SBIRT-PTSD)

Attendance at Treatment | PTSD, Substance Use, and Attendance at Treatment

United States
AO Clinical Investigation and Publishing Documentation

Terminated

TMT Fusion Plate vs. Two Crossed Screws (TMT)

Clinical Indication for First Metatarsal Joint Arthrodesis

United States, Colombia, United Kingdom
The Brandon Centre, London

Unknown

A Trial of Multisystemic Therapy in UK a Statutory Therapeutic Intervention for Young Offenders

Participants Are Male and Female Adolescents 13-16 Years at Risk for Continuing to Commit Criminal Offences.

United Kingdom
University of Pittsburgh
National Center for Complementary and Integrative Health (NCCIH)

Completed

The Healing Context in CAM: Instrument Development and Initial Validation - Calibration Study (HEAL2)

Persons Receiving Any Medical or Behavioral Treatment (Focus of Study is Questionnaires)

United States
River 3 Renal Corp.

Recruiting

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Focal Segmental Glomerulosclerosis | Alport Syndrome

United States, Belgium, United Kingdom, France, Germany, Netherlands
Imperial College Healthcare NHS Trust

Recruiting

Bioimpedence and Arterial Function Monitoring at Birth and in Infants (BAMBI)

Pre-Eclampsia | Fetal Growth Retardation | Arterial Stiffness | Small for Gestational Age at Delivery

United Kingdom
Northwestern University

Recruiting

Surgical Approach to Uterine Septum

Treatment Side Effects | Treatment | Surgical Complication | Uterine Septum | Septum; Uterus

United States
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Incentive-based Smoking Cessation for Methadone Patients

Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence

United States
Brainsway

Unknown

Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

United States
NHS Greater Glasgow and Clyde
University of Central Lancashire

Completed

Comparing Clinical Outcomes Using Two Insole Manufacture Techniques

Foot Ankle Injuries | Foot Injury | Foot Deformity | Foot Sprain | Feet, Flat

United Kingdom
Pop Test Oncology LLC
Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Congressionally... and other collaborators

Completed

Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)

Potential Treatment for Alcohol Dependence-Alcohol Interaction

United States
Children's Health Ireland
Belfast Health and Social Care Trust; University of Edinburgh; University Hospital... and other collaborators

Recruiting

Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome (REFRESHED)

Quality of Life | Obstructive Sleep Apnea | Down Syndrome | Behavior | Adherence, Treatment

United Kingdom, Ireland
Oxford University Hospitals NHS Trust

Recruiting

Investigating the Structured Use of Ultrasound Scanning for Fetal Growth (OxGRIP)

Fetal Growth Retardation | Intrauterine Growth Restriction | Perinatal Death | Fetal Death | Stillbirth | Small for Gestational Age | Fetal Growth Restriction

United Kingdom
Boehringer Ingelheim

Recruiting

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

Healthy

United Kingdom
Amgen

Completed

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Treatment for Prevention of Chronic Migraine

United States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway
Lombard Medical

Withdrawn

Evaluation of EndoRefix Endovascular Delivery System and Staple (EndoRefix)

AAA Graft Implant for Primary Aneurysm Treatment | AAA Graft Repair to Extend Life of Implant

United States

Clinical Trials on Treatment for Submental Fat in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations